Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Shares Issued (2016 - 2025)

Veracyte's Shares Issued history spans 14 years, with the latest figure at $3.5 million for Q4 2025.

  • For Q4 2025, Shares Issued rose 7.54% year-over-year to $3.5 million; the TTM value through Dec 2025 reached $14.1 million, down 29.57%, while the annual FY2025 figure was $14.1 million, 29.57% down from the prior year.
  • Shares Issued for Q4 2025 was $3.5 million at Veracyte, down from $5.8 million in the prior quarter.
  • Across five years, Shares Issued topped out at $583.2 million in Q4 2021 and bottomed at $340000.0 in Q2 2022.
  • The 5-year median for Shares Issued is $3.0 million (2024), against an average of $32.3 million.
  • The largest annual shift saw Shares Issued tumbled 99.69% in 2022 before it surged 387.83% in 2024.
  • A 5-year view of Shares Issued shows it stood at $583.2 million in 2021, then crashed by 99.69% to $1.8 million in 2022, then dropped by 1.99% to $1.8 million in 2023, then skyrocketed by 84.2% to $3.3 million in 2024, then rose by 7.54% to $3.5 million in 2025.
  • Per Business Quant, the three most recent readings for VCYT's Shares Issued are $3.5 million (Q4 2025), $5.8 million (Q3 2025), and $1.8 million (Q2 2025).